Bacillus Calmette-Guérin (BCG) therapy for bladder cancer: an update

S Guallar-Garrido, E Julián - ImmunoTargets and therapy, 2020 - Taylor & Francis
Physicians treating patients affected by nonmuscle-invasive bladder cancer (NMIBC) have
been in shock during the last six years since manufacturing restrictions on the production of …

[HTML][HTML] Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect

J Han, X Gu, Y Li, Q Wu - Biomedicine & pharmacotherapy, 2020 - Elsevier
Over 30 years' successful application of Bacillus Calmette Guerin (BCG) to the clinical
treatment of bladder cancer has proved it one of the most promising immunotherapies for …

Performance of narrow band imaging (NBI) and photodynamic diagnosis (PDD) fluorescence imaging compared to white light cystoscopy (WLC) in detecting non …

GI Russo, TN Sholklapper, A Cocci, G Broggi… - Cancers, 2021 - mdpi.com
Simple Summary Bladder cancer is one of the most common malignancies in the United
States with a majority of patients diagnosed with non-muscle invasive bladder cancer …

An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer

M Ferro, MD Vartolomei, GI Russo, F Cantiello… - World journal of …, 2019 - Springer
Purpose The body mass index (BMI) may be associated with an increased incidence and
aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the …

Systemic inflammatory markers and oncologic outcomes in patients with high-risk non–muscle-invasive urothelial bladder cancer

F Cantiello, GI Russo, MD Vartolomei… - European urology …, 2018 - Elsevier
Background Serum levels of neutrophils, platelets, and lymphocytes have been recognized
as factors related to poor prognosis for many solid tumors, including bladder cancer (BC) …

Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review

K Mori, N Miura, M Babjuk, PI Karakiewicz… - … Oncology: Seminars and …, 2020 - Elsevier
Purpose: This systematic review assessed compliance to guidelines for the management of
nonmuscle-invasive bladder carcinoma (NMIBC). Methods: The PUBMED, Web of Science …

A systematic review of the use of social media for dissemination of clinical practice guidelines

NR Bhatt, SW Czarniecki, H Borgmann… - European Urology …, 2021 - Elsevier
Context Clinical practice guideline (CPG) uptake does not occur spontaneously and
requires active implementation, especially for long-term implementation. Social media …

Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine …

JJ Levy, N Chan, JD Marotti, NJ Rodrigues… - Cancer …, 2023 - Wiley Online Library
Background Urine cytology is generally considered the primary approach for screening for
recurrence of bladder cancer. However, it is currently unclear how best to use cytological …

[HTML][HTML] The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer

F Soria, G Marra, D D'Andrea, P Gontero… - … andrology and urology, 2019 - ncbi.nlm.nih.gov
The second look transurethral resection of the bladder (TURB) represents a fundamental
step in the treatment of papillary non-muscle invasive bladder cancer (NMIBC); it is therefore …

The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study

FHM van Osch, SHJ Jochems, RC Reulen… - Cancer Causes & …, 2018 - Springer
Background Smoking is a major risk factor for bladder cancer, but the relationship between
smoking cessation after initial treatment and bladder cancer recurrence has been …